LUMOSA THERAPEUTICS
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases of unmet medical needs. The company is actively engaged in scientific in-licensing and new drug development under the “reSEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced cross-functional teams of translational research, CMC, preclinical, clinical development, project management, regulatory affairs, intellectual property and business development experts.
LUMOSA THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.lumosa.com.tw
Total Employee:
101+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.lumosa.com.tw Semrush global rank: 9.22 M Semrush visits lastest month: 192
- Host name: 125-227-145-14.hinet-ip.hinet.net
- IP address: 125.227.145.14
- Location: Taipei Taiwan
- Latitude: 25.0478
- Longitude: 121.5318
- Timezone: Asia/Taipei
More informations about "Lumosa Therapeutics"
Lumosa Therapeutic Organization Chart | Lumosa …
ORGANIZATION AND TEAMS. Lumosa Team. Su-Chi Wang. Chairperson. Expertise. Other Positions. Chairman (rep.)/CIO/COO Center Laboratories, Inc. ... Director, Pre-clinical Development Division, Lumosa Therapeutics; Naomi Liu. …See details»
Lumosa Therapeutics
About Mission and Milestones Organization & Team Awards. Pipeline Neuroscience Oncology. ... Company introduction. Lumosa Therapeutics is a clinical-stage pharmaceutical company …See details»
Lumosa Therapeutics - Crunchbase Company Profile
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of …See details»
Lumosa Therapeutics | Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs. We actively engage …See details»
Member Profile - TRPMA Official Website
Lumosa Therapeutics (Lumosa) is dedicated to the development of innovative new drugs for the treatment of unmet medical needs in the fields of neurological and inflammatory diseases. Lumosa is actively engaged in scientific licensing …See details»
Center Ventures | Lumosa Therapeutics
Lumosa Therapeutics was publicly listed on Taipei Exchange in 2016 (Stock Code: 6535). Naldebain® was approved by Taiwan Food and Drug Administration (TFDA) in 2017. …See details»
Lumosa Therapeutics
Lumosa conducted a complete re-election of nine directors on May 2, 2024, including four independent directors. ... Executive Director and Chairperson of the Industry Committee of …See details»
Lumos Introduces Industry's First Autonomous Identity Platform ...
4 days ago Lumos helps us automate policy creation and lifecycle management, so we can stay ahead of threats, simplify user access reviews, and make joiner-mover-leaver workflows run …See details»
Lumosa Therapeutics - Center Ventures
11 rows Lumosa Therapeutics was publicly listed on Taipei Exchange in 2016 (Stock Code: 6535). Naldebain® was approved by Taiwan Food and Drug Administration (TFDA) in 2017. …See details»
Lumosa Therapeutics
About Mission and Milestones Organization & Team Awards. Pipeline Neuroscience Oncology. ... Currently, there are 6 directors and 4 independent directors in Lumosa's Board of Directors. …See details»
Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs. ... About Mission and Milestones Organization & Team …See details»
Lumosa Therapeutics
Dec 5, 2023 About Mission and Milestones Organization & Team Awards. Pipeline Neuroscience Oncology. ... Center Lab Group Executive Takes Helm as New Lumosa Chairman to Drive …See details»
Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs. ... About Mission and …See details»
Lumosa Therapeutics
Lumosa's main suppliers are domestic and foreign pharmaceutical R&D service companies and universities, which are industries that focus on the environment and society. Before forming a …See details»
Lumosa Therapeutics
The composition, responsibilities and operation of the Remuneration Committee： 1. Information of the members of the Remuneration Committee The responisibility of the Remuneration …See details»
Lumosa Therapeutics
Lumosa staffs have been teaching courses in the biomedical departs of various universities for 7 years now, sharing new drug development experience and career planning courses. ...See details»
Lumosa Therapeutics
2022 Lumosa Annual Report: About Mission and Milestones Organization & Team Awards. Pipeline Neuroscience Oncology. Latest News Finance Corporate. Investors Finance …See details»
Lumosa Therapeutics
Dec 3, 2024 Lumosa will disclose relevant data in detail in accordance with Shanghai Pharmaceutical’s notification and announcement in the future. (2) Explanations for not …See details»
Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs. ... About Mission and …See details»
Lumosa Therapeutics
May 14, 2024 Lumosa's marketed long-acting analgesic LT1001 has obtained marketing approvals across six countries to date and will continue to pursue niche market opportunities …See details»